DeCAF: a novel method to identify cell-type specific regulatory variants and their role in cancer risk

Genome Biol. 2022 Jul 8;23(1):152. doi: 10.1186/s13059-022-02708-9.

Abstract

Here, we propose DeCAF (DEconvoluted cell type Allele specific Function), a new method to identify cell-fraction (cf) QTLs in tumors by leveraging both allelic and total expression information. Applying DeCAF to RNA-seq data from TCGA, we identify 3664 genes with cfQTLs (at 10% FDR) in 14 cell types, a 5.63× increase in discovery over conventional interaction-eQTL mapping. cfQTLs replicated in external cell-type-specific eQTL data are more enriched for cancer risk than conventional eQTLs. Our new method, DeCAF, empowers the discovery of biologically meaningful cfQTLs from bulk RNA-seq data in moderately sized studies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alleles
  • Genome-Wide Association Study / methods
  • Neoplasms* / genetics
  • Polymorphism, Single Nucleotide*
  • Quantitative Trait Loci
  • RNA-Seq